TCL Archive Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds May 27, 2005
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: Calabresi Named DCT Board Chairman; NCI Gets $5 Million Gifts for Intramural Breast Cancer Work June 20, 1986
